Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, further to letter dated 28.03.2022, Vivimed Labs has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 30th Day of May, 2022 at Hyderabad to consider and approve, audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2022. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations the company has intimated its ‘Designated Persons including Directors’ regarding the closure of trading window from 01.04.2022 to till 48 hours after the declaration of audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2022.
The above information is a part of company’s filings submitted to BSE.
